AwardedFranceServices
Développement d'un inhibiteur pour une nouvelle cible thérapeutique (Hit to lead)
- Published
- Published 11 June 2025
- Deadline
- Closed 9 July 2025
Overview
We seek to develop an inhibitor against a newly identified therapeutic target in our laboratory.
Our focus will be on a chemical series derived from HTS screening, which has subsequently
been optimized during a hit expansion phase. This request for proposal (RFP) concerns a hitto-lead optimization phase, which is expected to last for six months. The goal is to strengthen
the structure-activity relationship (SAR) of our chemical series.
Key details
- Country
- France
- Status
- Awarded
- Category
- Services
- Procedure
- Open
- Published
- 11 June 2025
- Deadline
- Closed
Research and experimental development services
Award outcome
- Awarded value
- €480,120
- Award date
- 24 July 2025
- Contract period
- — → 19 July 2026
- Evotec International GmbH
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
6 August 2025
Contract Notice
8 July 2025
Contract Notice
11 June 2025
Contracting authority
INSTITUT CURIE
Procuring entityPARIS, France
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.